LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION April 25, 2023 TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB2212 by Blanco (relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources. Local Government ImpactNo significant fiscal implication to units of local government is anticipated. Source Agencies: b > td > 515 Board of Pharmacy LBB Staff: b > td > JMc, NPe, SLee
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 25, 2023
TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB2212 by Blanco (relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), Committee Report 1st House, Substituted
TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB2212 by Blanco (relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), Committee Report 1st House, Substituted
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
SB2212 by Blanco (relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), Committee Report 1st House, Substituted
SB2212 by Blanco (relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 515 Board of Pharmacy
515 Board of Pharmacy
LBB Staff: b > td > JMc, NPe, SLee
JMc, NPe, SLee